Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
38.78
-1.44 (-3.57%)
At close: Dec 5, 2025, 4:00 PM EST
38.78
0.00 (0.00%)
After-hours: Dec 5, 2025, 5:52 PM EST
Immunocore Holdings Revenue
Immunocore Holdings had revenue of $103.69M in the quarter ending September 30, 2025, with 29.22% growth. This brings the company's revenue in the last twelve months to $379.59M, up 28.10% year-over-year. In the year 2024, Immunocore Holdings had annual revenue of $310.20M with 24.37% growth.
Revenue (ttm)
$379.59M
Revenue Growth
+28.10%
P/S Ratio
5.13
Revenue / Employee
$769,959
Employees
493
Market Cap
1.96B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 310.20M | 60.77M | 24.37% |
| Dec 31, 2023 | 249.43M | 75.07M | 43.05% |
| Dec 31, 2022 | 174.36M | 137.88M | 377.91% |
| Dec 31, 2021 | 36.48M | -4.63M | -11.26% |
| Dec 31, 2020 | 41.11M | 7.12M | 20.94% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
IMCR News
- 25 days ago - Immunocore to present at upcoming investor conferences - GlobeNewsWire
- 27 days ago - Immunocore: Continuing To Improve The Bottom Line, But Needing A Big Catalyst - Seeking Alpha
- 4 weeks ago - Immunocore presents Phase 1 data for hepatitis B candidate at AASLD's The Liver Meeting - GlobeNewsWire
- 4 weeks ago - Immunocore reports third quarter financial results and provides a business update - GlobeNewsWire
- 3 months ago - Immunocore Holdings Plc (IMCR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 4 months ago - Immunocore Holdings plc (IMCR) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Immunocore (IMCR) Q2 Revenue Jumps 30% - The Motley Fool
- 4 months ago - Immunocore reports second quarter financial results and provides a business update - GlobeNewsWire